| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |